Unveiling prostatic inflammation to optimize management of lower urinary tract symptoms: a discussion with experts.

Mauro Gacci, Cosimo De Nunzio, Stavros Gravas

Journal: Biomarkers in medicine 2024;17(18):739-745

PMID: 37970796

Abstract

Benign prostatic obstruction (BPO) and associated lower urinary tract symptoms (LUTS) are common conditions in men, which increase in frequency and severity with age, and have a significant impact on quality of life. Chronic prostatic inflammation is increasingly being recognized as a key component of BPO. This may lead to new targets for the management of BPO/LUTS. This podcast is based on presentations from a symposium titled 'Unveiling prostatic inflammation to optimize LUTS management' held at the European Association of Urology 2023 Congress. The presenters outline evidence of a role for prostatic inflammation in the development and progression of BPO/LUTS, approaches to the identification of biomarkers of inflammation, and the implications of prostatic inflammation for the optimal management of BPO/LUTS.

Address: Department of Minimally Invasive & Robotic Urologic Surgery & Kidney Transplantation, Careggi University Hospital, Florence, Italy.; Department of Experimental & Clinical Biomedical Science, University of Florence, Florence, Italy.; Department of Molecular & Clinical Medicine, Faculty of Medicine & Psychology, Sapienza University of Rome, Rome, Italy.; Division of Urology, Sant'Andrea Hospital, Rome, Italy.; Department of Urology, Medical School, University of Cyprus, Nicosia, Cyprus.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.